Skip to content

Biomaterial Clinical Performance in a Socket Preservation Model

Comparative Clinical Performance of Biphasic Calcium Sulfate Cement Matrix With Hydroxyapatite Granules in a Socket Preservation Model: a Pilot Clinical Trial Parallel Group Assignment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04789759
Enrollment
20
Registered
2021-03-10
Start date
2021-05-01
Completion date
2022-08-01
Last updated
2021-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Resorption, Bone Loss

Brief summary

When a dental extraction is performed, sequential cascade of events happens that lead to a modeling and remodeling of the area. This phenomenon leads to bone resorption and consequential volume loss atrophy. In literature several biomaterials (Autogenous, alloplastic, allografts and xenografts) were tested as alveolar fillers with the aim of controlling this physiologic event. Socket preservation is today a very widely spread dental technic to preserve the alveolar dimensions, that uses a wide range of biomaterials. Alloplastic materials have a fair evidence to work in several regenerative procedures in the oral and maxillofacial region. This pilot trial aims to characterize Histologic bone healing pattern in a human socket preservation model of 2/3 biphasic calcium sulfate cement matrix's and Hydroxyapatite (HA granules). Alterations in Volumetric alveolar socket changes in a socket preservation clinical model will also be studied.

Detailed description

Aim : To evaluate histologic performance and volumetric outcome of a bone substitute used in dentistry for guided bone regeneration procedures. Model : Human Socket preservation surgery with a control group of spontaneous alveolar healing. Inclusion criteria includes a class 2 or 3 (loss of at least 1/3 of the buccal bone of the alveolar socket) post-extraction sockets. Clinical Experimental Methodology : Atraumatic extraction of the hopeless tooth without flap retraction, after socket mechanical debridement , fill with 2/3 biphasic calcium sulfate cement matrix's with Hydroxyapatite (HA granules) and covered with a resorbable membrane. 3 Month after a CBCT is performed for implant planning. At implant placement a 2 mm trephine will be used for core extraction. Measurements (Stl File) on the day of surgery (Baseline T0) and at implant placement (3 month after tooth extraction) (T1) and after delivery final crown (T2). Discrepancy (Trueness) Between STL Files in Teeth Adjacent to Implant will be used at T0, T1 and T2. Histologic measure comprise percentage of vital bone formation, fibrous/connective tissue, and material remnant, in a socket preservation model To Measure Volumetric changes reverse engineering software (Geomagic Control X, 3D Systems) will be used. Other evaluation parameters involve radiographic Cone Beam Computer Tomography evaluation, primary stability, implant survival and implant success rate Clinical Control Methodology : Atraumatic extraction of the hopeless tooth without flap retraction, after socket mechanical debridement Measurements (Stl File) on the day of surgery (Baseline T0) and at 3 month after tooth extraction) (T1) Discrepancy (Trueness) Between Standard Tessellation Language Files in Teeth Adjacent to Implant will be used at T0 and T1

Interventions

DEVICESocket Preservation - Bond Apatite synthetic bone substitute

Pre-op CBCT scanner for evaluating bone conditions around hopeless tooth. If 1/3 of the buccal plate is missing, considered a class 2 alveolar socket. Extraction of tooth and place 2/3 biphasic calcium sulfate cement matrix's with Hydroxyapatite (HA granules) , condensed , and covered with a resorbable membrane suture to the adjacent tissue. At implant placement ,take bone for histological preparation and histomorphometric analysis of the healing pattern. At T0, T1 and T2 measure adjacent teeth periodontal status , Probing Depth , bleeding on probing. Volumetric measurements, will use fixed landmarks (ex. adjacent teeth) to calibrate the STL measurements. Calculate the difference between pre-extraction socket and the post treatment with the alloplastic material. Primary and secondary stability will be measured by ISQ units with a RFA machine, that will include the machine to measure and the magnetic tip to be screwed in the implant platform.

PROCEDURESocket healing - No Filler

Pre-op CBCT scanner for evaluating bone conditions around hopeless tooth, at extraction day, no flap opening , atraumatic extraction, no biomaterial filler, At T0, T2 measure adjacent teeth periodontal status , Probing Depth , bleeding on probing. Volumetric measurements will include an intramural scanner from all the stages , we will use fixed landmarks (ex. adjacent teeth) to calibrate the STL measurements. Calculate the difference between pre-extraction socket and the post treatment with the alloplastic material.

Sponsors

International Advanced Dentistry, Lisbon
Lead SponsorNETWORK

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Person who does the volumetric analysis is blinded, Person who makes data treatment is blinded

Intervention model description

Case Series of 10 consecutive cases , with one extraction (at least ) with a type 2 socket, Control group, 10 consecutive dental extractions.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Aged 18 or over 2. requiring extraction of teeth in the premolar region and anterior maxilla (15-25), presence of intact 2/3 or less, buccal bone plate 3. ASA (Physical Status Classification System, American Society of Anesthesiologist) I or II.

Exclusion criteria

1. patients with uncompensated systemic diseases, metabolic and healing disorders, i.e. diabetes mellitus, hyperparathyroidism, cancer, HIV, 2. heavy smokers (\>5 cigarettes/ day), 3. bone metabolic diseases, 4. severe renal dysfunction or liver disease, 5. had received systemic corticosteroids or other immunosuppressive agents, radiation therapy and/or chemotherapy for the past 2 months, 6. active infections in the surgical site 7. patients with periodontal or/and endodontic disease

Design outcomes

Primary

MeasureTime frameDescription
Histologic Examination Histomorphometric Analysis3 month after tooth extractionHistologic measure, percentage of Vital Bone formation, Fibrous/connective tissue, and material remnant present in the sample.

Secondary

MeasureTime frameDescription
Radiographic CBCT - Bone evaluationat pre-extraction and at final crown insertion up to 1 yearMeasure Linear changes in bone from T0 baseline to Implant Placement T1 in mm
Primary and Secondary stabilityat implant placement and at dental crown insertion up to 1 yearMeasure the Resonance Frequency Analysis at implants placed in regenerated bone
Incidence of Implant Success rateat final treatment (crown insertion) up to 1 yearMeasure implant status peri-implant parameters , bleeding on probing in percentage of sites
Volumetric Changes Clinicalat pre-extraction and at final crown insertion up to 1 yearMeasure Linear changes reverse engineering software (Geomagic Control X, 3D Systems) in mm.
Implant marginal bone loss.at implant placement and at final crown insertion (up to 1 year)Measure bone position regarding Implant Platform
Incidence of Survival rateat dental crown placement (final treatment) up to 1 yearif the implant is osseointegrated
Implant probing depthAt implant insertion and At final treatment (crown insertion) up to 1 yearMeasure the attachment loss in mm

Contacts

Primary ContactAndre Chen, Phd
ac@iadlisbon.com00351919774343
Backup ContactJoana Borges
jfb@iadlisbon.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026